| 常用名 | Mavoglurant | CAS号 | 543906-09-8 |
|---|---|---|---|
| 价格 | 纯度 | 99.0% | |
| 备货期 | 10天 | 库存 | 现货 |
| 产品详情(用途,包装等)
用途: Mavoglurant is a structurally novel, non-competitive mGlu5 receptor antagonist, has an IC50 of 30 nM in a functional assay with human mGluR5.IC50 value: 30 nMTarget: mGluR5in vitro: Mavoglurant is a selective non-competitive antagonist which showed efficacy in the treatment of L-dopa induced dyskinesias in Parkinson's disease and Fragile X mental retardation in proof of principle studies. Mavoglurant is selective over the other mGluR subtypes, iGluRs and a panel of 238 CNS relevant receptors, transporter or enzymes. [1]In vivo: Mavoglurant shows an improved pharmacokinetic profile in rat and efficacy in the stress-induced hyperthermia test in mice as compared to the prototypic mGluR5 antagonist MPEP.[1] 物理化学性质: CAS号:543906-09-8 常用中文名:Mavoglurant 常用英文名:mavoglurant 分子式:C19H23NO3 分子量:313.391 密度:1.2±0.1 g/cm3 沸点:476.3±45.0 °C at 760 mmHg 熔点:N/A 闪点:241.8±28.7 °C 储存条件:2-8℃ |